“Digital PCR (dPCR) and Real-time PCR (qPCR) Market to Reach Valuation of 8,860.22 USD Million by 2028; Increase in Incidence of Targeted Infectious Diseases & Genetic Disorders is Fuelling the Demand for the Digital PCR (dPCR) and Real-time PCR (qPCR) Market”

Vantage Market Research

Mar 16, 2022

In terms of revenue, the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is expected to reach 8,860.22 USD Million by 2028, growing at a CAGR of 8.80% from 2022 to 2028.

Increasing incidence & prevalence of genetic & infectious diseases; technological advancement in PCR; and rising number of CRO, forensic, and other research laboratories are driving the growth in the dPCR and qPCR market. Moreover, emerging opportunities from Asian countries and the transition from plant to genome-based drug discovery will provide high opportunities for this market in the forecast period. On the other hand, technical limitations associated with PCR and the high cost of PCR devices are expected to restrict the growth of this market.

Key Findings:

  • The hospitals and diagnostic sub-segment are anticipated to dominate the end-user segment for Digital PCR (dPCR) and Real-time PCR (qPCR) Market. The rise in this segment is owing to qPCR reagents in clinical diagnostic applications and the ongoing expansion of healthcare infrastructure across emerging countries.
  • The clinical application segment is accounted for the largest market share in 2021. Device sensitivity, better precision, and absolute quantification of target molecule are the key reasons for this segment to flourish.
  • North America is the largest regional segment. This surge is attributed to the rising demand for digital PCR & real-time PCR in developed economies such as the U.S. and Canada.

Some of key players in Digital PCR (dPCR) and Real-time PCR (qPCR) Market include, [object Object].

More than 20 billion people worldwide have been infected with the hepatitis B virus (HBV), and HBV is a common cause of liver diseases and liver cancers. The fatality of these diseases as well as their relation to hepatitis infection is well-established; 600,000 HBV-related deaths are estimated to occur every year and 73% of liver cancer deaths worldwide are due to hepatitis viruses, with a higher prevalence in developing countries.

North America is expected to dominate the global Digital PCR (dPCR) and Real-time PCR (qPCR) Market in 2021 and is likely to continue the same trend during the forecast period. An increase in government initiatives and support in the healthcare industry is likely to generate demand in this region for this market in near future. An increase in R&D for developing new techniques in digital PCR and real-time PCR in the healthcare industry in countries such as U.S. & Canada are further adding spotlight. Significant improvements in the clinical infrastructure, especially in the developing economies, are providing a thrust to the Digital PCR (dPCR) and Real-time PCR (qPCR) Market growth.

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.